Corindus robotic-assisted CorPath 200 system wins FDA nod
05:16 EDT 26 Jul 2012 | Medical Business Review
The US Food and Drug Administration (FDA) has granted 510(k) clearance to Corindus Vascular Robotics' CorPath 200 system, designed to restore blood flow to blocked arteries in patients with coronary artery disease.
Original Article: Corindus robotic-assisted CorPath 200 system wins FDA nod
More From BioPortfolio on "Corindus robotic-assisted CorPath 200 system wins FDA nod"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
